CIC
UTHR icon

Cornercap Investment Counsel’s United Therapeutics UTHR Stock Holding History

Cornercap Investment Counsel’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,027
Closed -$715K – 434
2024
Q4 		$715K Hold
2,027
– – 0.23% 127
2024
Q3 		$726K Sell
2,027
-3,257
-62% -$1.1M 0.21% 145
2024
Q2 		$1.68M Sell
5,284
-84
-2% -$22.2K 0.27% 101
2024
Q1 		$1.23M Buy
5,368
+225
+4% +$50.8K 0.19% 159
2023
Q4 		$1.13M Sell
5,143
-4
-0.1% -$922 0.19% 180
2023
Q3 		$1.16M Sell
5,147
-62
-1% -$14.3K 0.21% 125
2023
Q2 		$1.15M Hold
5,209
– – 0.2% 145
2023
Q1 		$1.17M Buy
5,209
+294
+6% +$72.5K 0.21% 132
2022
Q4 		$1.37M Sell
4,915
-967
-16% -$244K 0.24% 107
2022
Q3 		$1.23M Sell
5,882
-875
-13% -$196K 0.23% 115
2022
Q2 		$1.59M Buy
6,757
+34
+0.5% +$6.91K 0.28% 96
2022
Q1 		$1.21M Buy
6,723
+371
+6% +$70.7K 0.13% 205
2021
Q4 		$1.37M Buy
6,352
+52
+0.8% +$10.2K 0.2% 134
2021
Q3 		$1.16M Sell
6,300
-276
-4% -$54.4K 0.13% 246
2021
Q2 		$1.18M Sell
6,576
-847
-11% -$161K 0.13% 261
2021
Q1 		$1.24M Buy
+7,423
New +$1.24M 0.14% 240
2020
Q4 		– Sell
-8,081
Closed -$816K – 607
2020
Q3 		$816K Buy
+8,081
New +$887K 0.12% 294

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Cornercap Investment Counsel's UTHR Position: Q1 2025 in Review

Cornercap Investment Counsel sold out of United Therapeutics (UTHR) in Q1 2025, closing a stake of 2,027 shares — an estimated $715K sold.

Cornercap Investment Counsel first reported a position in UTHR in Q3 2020 and held it in 17 quarters. The position peaked at $1.68M in Q2 2024. 673 funds tracked by Wall St. Rank hold UTHR as of Q1 2025.

  • Cornercap Investment Counsel reported no remaining United Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Cornercap Investment Counsel sold 2,027 United Therapeutics shares in Q1 2025, an estimated $715K.
  • Cornercap Investment Counsel first reported a position in United Therapeutics in Q3 2020 and held it in 17 quarters.
  • Cornercap Investment Counsel's United Therapeutics position peaked at $1.68M in Q2 2024.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2025.

Based on Cornercap Investment Counsel's 13F filing for Q1 2025, filed 2 May 2025.